Lion's Mane Mushroom Benefits: NGF, Brain Health and Cognition

Short answer: lion's mane is studied for cognition through a specific mechanism — its hericenones and erinacines appear to stimulate nerve growth factor (NGF) production in neural tissue. That mechanism is established in laboratory work. The human evidence is thinner than the marketing suggests: one well-known 16-week trial in adults with mild cognitive impairment, and a small 2023 pilot study in healthy young adults with mixed results.

What makes lion's mane neurologically distinctive

Most functional mushrooms are studied for immune effects via beta-glucans. Lion's mane has those too, but its distinctive interest lies in two classes of small neuroactive compounds: hericenones, concentrated in the fruiting body, and erinacines, concentrated in the mycelium.

Laboratory work published in the International Journal of Medicinal Mushrooms (2013) characterised the neurotrophic properties of Hericium erinaceus extracts in neural cell culture. This is in vitro evidence for the mechanism — it is not a clinical outcome, and should not be read as one.

What NGF does

Nerve growth factor is a neurotrophin supporting the survival, growth and differentiation of neurons, particularly cholinergic neurons in the basal forebrain that underpin attention and memory. NGF availability declines with normal ageing.

To be clear about the boundary: this is a description of normal neurobiology, not a claim that lion's mane treats or prevents any neurological condition. It does not, and no supplement should be presented that way.

The blood-brain barrier question

NGF is a protein and does not cross the blood-brain barrier. The lion's mane compounds are small molecules that can. That is the basis of the proposed mechanism: the compounds cross into the brain and encourage local NGF production, rather than delivering NGF from outside.

The human evidence, stated honestly

The most-cited trial is the double-blind, placebo-controlled study in Phytotherapy Research (2009). It enrolled 30 adults with mild cognitive impairment; the lion's mane group scored significantly higher on a cognitive function scale after 16 weeks, and scores drifted back toward baseline within four weeks of stopping — suggesting the effect depends on continued use.

A separate four-week trial in Biomedical Research (2010) reported reductions in self-reported depression and anxiety measures in a small group of women — a mood outcome rather than a cognitive one.

The most relevant study for healthy people is a 2023 pilot published in Nutrients, which gave 1.8 g of Hericium erinaceus to 41 healthy adults aged 18–45. Its results were genuinely mixed and are worth stating precisely: participants performed faster on a Stroop task 60 minutes after a single dose, and after 28 days there was a trend toward reduced subjective stress that did not reach statistical significance. The authors also reported null and some negative findings, and cautioned that the sample was small.

An earlier version of this page described that study as finding improvements in processing speed and attention after 28 days. That was an overstatement — the speed effect was acute, and the 28-day result was a non-significant trend. We have corrected it.

Why fruiting body and mycelium both matter

Hericenones concentrate in the fruiting body; erinacines concentrate in the mycelium. A product using only one part misses the other's compounds — and mycelium grown on grain carries filler that inflates the weight without adding actives.

AE·ORA Lion's Mane uses a dual extract of both at 1,000 mg per serving, standardised to 40% polysaccharides. Timing and expectations are covered in When to Take Lion's Mane.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.